We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEFL
7626
DELISTED
ETRACS Monthly Pay 2xLeveraged Closed-End Fund ETN
CEFL
$3K ﹤0.01%
+217
New +$3.44K
SCIN
7627
DELISTED
Columbia India Small Cap ETF
SCIN
$3K ﹤0.01%
+182
New +$3.53K
BOM
7628
DELISTED
DB Base Metals Double Short Exchange Traded Notes due June 1, 2038
BOM
$3K ﹤0.01%
491
ARLZ
7629
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$3K ﹤0.01%
+8,640
New +$7.09K
JJC
7630
DELISTED
iPath Series B Bloomberg Copper Subindex Total ReturnSM ETN
JJC
$3K ﹤0.01%
+165
New +$2.66K
INDF
7631
DELISTED
iShares Edge MSCI Multifactor Industrials ETF
INDF
$3K ﹤0.01%
+100
New +$3.11K
AEHL icon
7632
Antelope Enterprise Holdings
AEHL
$8.63M
-1
Closed -$11.6K
BOTZ icon
7633
PUT
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
$2K ﹤0.01%
100
BTG icon
7634
PUT
B2Gold
BTG
$5B
$2K ﹤0.01%
700
-24,300
-97% -$66.5K
CAPR icon
7635
Capricor Therapeutics
CAPR
$223M
$2K ﹤0.01%
126
+86
+215% +$1.17K
COHN icon
7636
Cohen & Co
COHN
$33.3M
$2K ﹤0.01%
220
-23,431
-99% -$253K
CPHI icon
7637
China Pharma Holdings
CPHI
$45M
$2K ﹤0.01%
18
-21
-54% -$2.83K
CSPI icon
7638
CSP Inc
CSPI
$79.7M
$2K ﹤0.01%
400
DHX icon
7639
DHI Group
DHX
$182M
$2K ﹤0.01%
790
+588
+291% +$1.19K
DOGZ icon
7640
Dogness International Corp
DOGZ
$12.8M
$2K ﹤0.01%
22
-131
-86% -$10.7K
DSWL icon
7641
Deswell Industries
DSWL
$51.6M
$2K ﹤0.01%
+607
New +$1.88K
DXLG icon
7642
Destination XL Group
DXLG
$31.2M
$2K ﹤0.01%
929
-4,043
-81% -$7.03K
ELTK icon
7643
Eltek
ELTK
$56.9M
$2K ﹤0.01%
620
-46
-7% -$184
EQH icon
7644
Equitable Holdings
EQH
$13B
$2K ﹤0.01%
+100
New +$2.13K
IGC icon
7645
IGC Pharma
IGC
$26M
$2K ﹤0.01%
+3,576
New +$2.06K
INUV icon
7646
Inuvo
INUV
$15.1M
$2K ﹤0.01%
216
ISMD icon
7647
Inspire Small/Mid Cap Impact ETF
ISMD
$332M
$2K ﹤0.01%
65
-135
-68% -$3.74K
JOB icon
7648
GEE Group
JOB
$23.1M
$2K ﹤0.01%
780
-1,182
-60% -$2.88K
KGC icon
7649
PUT
Kinross Gold
KGC
$27.4B
$2K ﹤0.01%
400
-39,600
-99% -$149K
MTNB icon
7650
Matinas BioPharma
MTNB
$1.88M
$2K ﹤0.01%
+88
New +$2.54K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.